Each year, the UBC Faculty of Medicine (FoM) recognizes faculty members who have made exceptional contributions in the areas of education, research and/or service, and who are dedicated to advancing both the Faculty’s values and vision of transforming health for everyone.
Two BC Cancer researchers are recipients of the 2025 UBC FoM Distinguished Achievement Awards in the following categories:
Congratulations to Dr. Ly Vu for receiving a Journey Award from the Canada Centre for Immigrant Women in STEM. The Journey Awards recognize and honour the journeys of immigrant women in STEMM who exemplify leadership, innovation and community service.
Dr. Vu is a scientist at BC Cancer, professor at UBC, and a Canada Research Chair in RNA biology in hematological malignancies.
Researchers with the Lockwood Lab at BC Cancer examined why certain lung tumours manage to resist treatment over time, and what can be done to reduce resistance.
Congratulations to Dr. Pamela Hoodless for receiving a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC).
Dr. Hoodless, a distinguished researcher and Interim Head, Basic and Translational Research at BC Cancer, will use the grant to support her work in defining cell lineages and plasticity in the developing liver.
A new BC Cancer project has been shown to expedite the triaging of breast cancers and accelerate the initiation of treatment.
The CAN-TRI-NLP, or a “CANcer TRIage system to expedite care with Natural Language Processing” project, was funded through the Ministry of Health's Innovation Pathway Program to explore a new expedited breast cancer triage system for faster initiation of appropriate treatment, chemotherapy or surgery.
The groundbreaking seventeen-year study involved researchers from UBC’s Faculty of Medicine as well as researchers at 55 sites across Canada, Australia and the United Kingdom.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.